Publish Date June 4, 2018 Encorafenib Plus Binimetinib for Metastatic Melanoma Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Print Share by Email Victor Sandor, MD, discusses the treatment combination at the ASCO 2018 meeting in Chicago. Victor Sandor, MD, discusses the treatment combination at the ASCO 2018 meeting in Chicago. Topics: ASCO 2018 Melanoma Skin Cancer